comorbidities and flares determinants in a very large population of gout patients. In line with current guidelines, [5] NSAIDs and colchicine were the drugs most commonly prescribed during an ...

A primary-outcome event occurred in 322 of 3528 patients (9.1%) in the colchicine group and 327 of 3534 patients (9.3%) in the placebo group over a median follow-up period of 3 years (hazard ratio ...

In COVID-19 patients, gout drug colchicine can reduce duration of oxygen therapy and hospital stay. Colchicine can be added to standard treatment for moderate to severe COVID-19 patients.

2023 Colchicine Still Needed in Allopurinol Up-Titration Strategy Patients taking colchicine had fewer gout flares than did those taking placebo for the first 6 months, but the number of flares ...

Colchicine, a cheap and readily available anti-inflammatory drug used to treat diseases such as gout, is to be investigated as a potential therapy for COVID-19 in the UK’s ground-breaking ...

If these medications are ineffective, your healthcare provider might prescribe Colcrys (colchicine ... can also help reduce ...